Additional funding was received by the STAEDTLER foundation, the Johannes und Frieda Marohn-Stiftung, the Else Krner-Fresenius Foundation, the Interdisciplinary Centre for Clinical Research, Erlangen (IZKF) and the Bundesministerium fr Bildung und Forschung (BMBF) BMBF-MASCARA TP No.4, the TEAM project of the European Union and the IMI-funded project EU IMI2-RTCure
Hunter CJ, Matyas JR, Duncan NA: Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison
Its important to note that while Dihexa has shown promise in preclinical studies, its safety and efficacy in humans have not been extensively studied
Currently, based on evidence from neuroimaging, postmortem studies, and cerebrospinal fluid testing, BBB dysfunction has been recognized as an early biomarker of neurodegenerative diseases (Yuan, et al
fainting or dizziness